Font:
GR

GRANULES / NSE / Biotechnology & Drugs

Granules India

INR 889.55123.10 (3.89%) 1D
Last updated: 2026-06-15T22:22:02.187993+00:00
Price Chart

1Y Price Trend

Open507.75
High804.3
Low432.6
Close748.5
Volume12,97,142
Change240.75
Change %47.42%

Key Information

Ticker SymbolGRANULES
Current Price889.55
52-Week High879.1
52-Week Low432.6
Market Cap21,721.53
Beta0.65
Volume12,97,142
ISININE101D01020
Day High772
Day Low739.85
Open769.95

Recommendations

RatingStrong Buy

Target High879

Target Low433

Target Mean1.75

Target Median93.75

Risk Metrics

Overall RiskBalanced risk

Board Risk31.92

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Granules India - Cemindia Projects among 8 small-cap stocks that hit 52-week highs, rally up to 35% in a month - The Economic Times2 days ago
Market news

Granules India - Cemindia Projects among 8 small-cap stocks that hit 52-week highs, rally up to 35% in a month The Economic Times

The era of the CIO who runs servers is over: Tushar Zade, Chief Transformation Officer, Granules India - Express Computer2 days ago
Market news

The era of the CIO who runs servers is over: Tushar Zade, Chief Transformation Officer, Granules India Express Computer

Granules India secures sole First-to-File status for generic drug - The Times of India3 days ago
Market news

Granules India secures sole First-to-File status for generic drug The Times of India

Granules secures FTF status for CNS depressant generic - The Hindu3 days ago
Market news

Granules secures FTF status for CNS depressant generic The Hindu

Granules India gets sole first-to-file status for narcolepsy drug Lumryz - Business Standard3 days ago
Market news

Granules India gets sole first-to-file status for narcolepsy drug Lumryz Business Standard

Granules India gains after securing sole first-to-file ANDA status for LUMRYZ generic - Business Standard3 days ago
Market news

Granules India gains after securing sole first-to-file ANDA status for LUMRYZ generic Business Standard

Glenmark, Granules shares gain after USFDA developments; check details here - CNBC TV183 days ago
Market news

Glenmark, Granules shares gain after USFDA developments; check details here CNBC TV18

Granules India gets key US advantage for Generic Lumryz Tablets - BusinessLine3 days ago
Market news

Granules India gets key US advantage for Generic Lumryz Tablets BusinessLine

FAQ

Stock FAQs

What is the NSE symbol for Granules India?

Granules India trades on NSE with the symbol GRANULES. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Granules India share price and chart?

You can track Granules India share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Granules India?

Yes. ShareKeyX displays available financial statements for Granules India using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Granules India?

Yes. ShareKeyX displays available historical OHLC candles for Granules India across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Granules India belong to?

Granules India is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Granules India?

Yes. ShareKeyX shows the latest available stock news for Granules India from the connected stock news source.